HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Erno Laszlo

This article was originally published in The Rose Sheet

Executive Summary

R.E.M. Intensive Night Therapy for Normal to Extremely Oily Skin works to repair, energize and "mattify" skin overnight. Ultrasomes technology and glycogen strengthen skin's defenses, decrease fine lines and diminish acne scars, according to Erno Laszlo. To invigorate skin and heal blemishes, the formula includes gingko, ginseng and hemolymph. An oil-absorbing system of myrhh extract and algae keeps skin shine-free, the company claims. On counter in September, the R.E.M. product will cost $85 for 2.5. oz. Also from Laszlo, Retinol Reparative Therapy For Eyes uses retinol to diminish the production of melanin, a contributor to under eye circles, while vitamin K serves as a natural lightening ingredient. Consumers can expect a 31% decrease in under eye darkness after three months. The .5 oz. therapy retails for $67 and will be available in November
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS006983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel